{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:51:07Z","timestamp":1790859067204,"version":"4.1.0"},"reference-count":86,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1762,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1111\/j.1365-2362.2010.02409.x","type":"journal-article","created":{"date-parts":[[2010,11,6]],"date-time":"2010-11-06T00:09:39Z","timestamp":1289002179000},"page":"323-333","source":"Crossref","is-referenced-by-count":38,"title":["Permanent neonatal diabetes mellitus - the importance of diabetes differential diagnosis in neonates and infants"],"prefix":"10.1111","volume":"41","author":[{"given":"Oscar","family":"Rubio-Cabezas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Klupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej T.","family":"Malecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CEED3 Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,4]]},"reference":[{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s001250051270","article-title":"Temporal, seasonal, and geographical incidence patterns of type I diabetes mellitus in children under 5\u2003years of age in Germany","volume":"42","author":"Rosenbauer","year":"1999","journal-title":"Diabetologia"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00125-002-0837-2","article-title":"Permanent diabetes mellitus in the first year of life","volume":"45","author":"Iafusco","year":"2002","journal-title":"Diabetologia"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1503\/cmaj.060244","article-title":"Type 1 diabetes: pathogenesis and prevention","volume":"175","author":"Gillespie","year":"2006","journal-title":"CMAJ"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/adc.2003.036608","article-title":"Acquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management","volume":"89","author":"Porter","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.2337\/diacare.22.12.1950","article-title":"Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group","volume":"22","author":"Komulainen","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s001250051137","article-title":"Islet autoantibodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15\u2003years of age","volume":"42","author":"Lindberg","year":"1999","journal-title":"Diabetologia"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2362.2010.02409.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.2337\/diabetes.54.suppl_2.S25","article-title":"Natural history of type 1 diabetes","volume":"54","author":"Achenbach","year":"2005","journal-title":"Diabetes"},{"issue":"Suppl. 12","key":"10.1111\/j.1365-2362.2010.02409.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1399-5448.2009.00571.x","article-title":"The diagnosis and management of monogenic diabetes in children and adolescents","volume":"10","author":"Hattersley","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.381","article-title":"Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes","volume":"41","author":"Barrett","year":"2009","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra0808284","article-title":"Genetics of type 1A diabetes","volume":"360","author":"Concannon","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2337\/db06-0094","article-title":"HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6\u2003months","volume":"55","author":"Edghill","year":"2006","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1172\/JCI117247","article-title":"Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives","volume":"93","author":"Schatz","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"17040","DOI":"10.1073\/pnas.0705894104","article-title":"The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes","volume":"104","author":"Wenzlau","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"882","DOI":"10.7326\/0003-4819-140-11-200406010-00009","article-title":"Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents","volume":"140","author":"Hummel","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2337\/dc08-1188","article-title":"Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes","volume":"32","author":"Rubio-Cabezas","year":"2009","journal-title":"Diabetes Care"},{"issue":"Suppl. 3","key":"10.1111\/j.1365-2362.2010.02409.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000091503","article-title":"Hormonal regulation of fetal growth","volume":"65","author":"Gicquel","year":"2006","journal-title":"Horm Res"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2337\/db07-1405","article-title":"Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood","volume":"57","author":"Edghill","year":"2008","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJM199509143331105","article-title":"Long-term course of neonatal diabetes","volume":"333","author":"von M\u00fchlendahl","year":"1995","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2362.2010.02409.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000053198","article-title":"Neonatal diabetes: new insights into aetiology and implications","volume":"53","author":"Shield","year":"2000","journal-title":"Horm Res"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20124","article-title":"KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes","volume":"25","author":"Massa","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-2-12","article-title":"Neonatal diabetes mellitus: a disease linked to multiple mechanisms","volume":"2","author":"Polak","year":"2007","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl.1","key":"10.1111\/j.1365-2362.2010.02409.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.2337\/diabetes.50.2007.S48","article-title":"Roles of ATP-sensitive K+ channels in cell survival and differentiation in the endocrine pancreas","volume":"50","author":"Miki","year":"2001","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2006-2490","article-title":"Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers","volume":"92","author":"Stanik","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00125-009-1416-6","article-title":"Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births","volume":"52","author":"Slingerland","year":"2009","journal-title":"Diabetologia"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/hmg\/ddi086","article-title":"Relapsing diabetes can result from moderately activating mutations in KCNJ11","volume":"14","author":"Gloyn","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa032922","article-title":"Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes","volume":"29","author":"Gloyn","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"17539","DOI":"10.1073\/pnas.0404756101","article-title":"Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features","volume":"14","author":"Proks","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2337\/diabetes.53.10.2713","article-title":"Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy","volume":"53","author":"Sagen","year":"2004","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.2337\/diabetes.53.10.2719","article-title":"Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients","volume":"53","author":"Vaxillaire","year":"2004","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ncpneuro0640","article-title":"Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11","volume":"3","author":"Mlynarski","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1007\/s00125-006-0407-0","article-title":"Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene","volume":"49","author":"Slingerland","year":"2006","journal-title":"Diabetologia"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.2337\/dc07-1196","article-title":"Sulfonylrea treatment in permanent neonatal diabetes due to G53D mutation in the KCNJ11 gene: improvement in glycemic control and neurological function","volume":"30","author":"Noffs","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1126\/science.1186146","article-title":"Muscle dysfunction caused by a KATP channel mutation in neonatal diabetes is neuronal in origin","volume":"329","author":"Clark","year":"2010","journal-title":"Science"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0014-5793(95)01369-5","article-title":"Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain, heart and skeletal muscle","volume":"377","author":"Sakura","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2337\/db05-1420","article-title":"Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy","volume":"55","author":"Proks","year":"2006","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","author":"Pearson","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1007\/s00125-006-0329-x","article-title":"Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene","volume":"49","author":"Tonini","year":"2006","journal-title":"Diabetologia"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1210\/jc.2004-1241","article-title":"Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2","volume":"89","author":"Zung","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2337\/dc09-0280","article-title":"Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: a previously unreported side effect","volume":"32","author":"Kumaraguru","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2337\/dc06-1628","article-title":"Transfer to sulphonylurea therapy of adult subjects with permanent neonatal diabetes due to KCNJ11 activating mutations: evidence for improvement in insulin sensitivity","volume":"30","author":"Malecki","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00125-005-1731-5","article-title":"The identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of \u03b2-cell function among carriers of the R201H mutation","volume":"48","author":"Klupa","year":"2005","journal-title":"Diabetologia"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/dia.2009.0165","article-title":"Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up","volume":"12","author":"Klupa","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1210\/jc.2010-0096","article-title":"The First Case Report of Sulfonylurea Use in a Woman with Permanent Neonatal Diabetes Mellitus due to KCNJ11 Mutation during a High-Risk Pregnancy","volume":"95","author":"Klupa","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2362.2010.02409.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1463-1326.2007.00772.x","article-title":"Mutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period","volume":"9","author":"Patch","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2337\/db06-1540","article-title":"New ABCC8 mutations in relapsing neonatal diabetes and clinical features","volume":"56","author":"Vaxillaire","year":"2007","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/hmg\/ddl101","article-title":"A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes","volume":"15","author":"Proks","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMoa055068","article-title":"Activating mutations in the ABCC8 gene in neonatal diabetes mellitus","volume":"355","author":"Babenko","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1086\/519174","article-title":"Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects","volume":"81","author":"Ellard","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2265.2008.03478.x","article-title":"Mutations in the ABCC8 (SUR1 subunit of the K(ATP) channel) gene are associated with a variable clinical phenotype","volume":"71","author":"Klupa","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/hmg\/ddm149","article-title":"Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome","volume":"16","author":"Proks","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2337\/dc07-1785","article-title":"Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations","volume":"31","author":"Rafiq","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"15040","DOI":"10.1073\/pnas.0707291104","article-title":"Insulin gene mutations as a cause of permanent neonatal diabetes","volume":"104","author":"Stoy","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2337\/diabetes.52.2.409","article-title":"Dominant nagative pathogenesis by mutant proinsulin in the Akita diabetic mouse","volume":"52","author":"Izumi","year":"2003","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1073\/pnas.0910533107","article-title":"Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis","volume":"107","author":"Garin","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2337\/diabetes.45.2.223","article-title":"Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm","volume":"45","author":"Matschinsky","year":"1996","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/humu.21110","article-title":"Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia","volume":"30","author":"Osbak","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJM200105243442104","article-title":"Neonatal diabetes mellitus due to complete glucokinase deficiency","volume":"344","author":"Nj\u00f8lstad","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/db07-1467","article-title":"Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes","volume":"57","author":"Molven","year":"2008","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2350-11-42","article-title":"Further evidence that mutations in INS can be a rare cause of Maturity-Onset Diabetes of the Young (MODY)","volume":"11","author":"Boesgaard","year":"2010","journal-title":"BMC Med Genet"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0197-106","article-title":"Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence","volume":"15","author":"Stoffers","year":"1997","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2337\/db09-1284","article-title":"A novel hypomorphic PDX1 mutation responsible for permanent neonatal diabetes with subclinical exocrine deficiency","volume":"59","author":"Nicolino","year":"2010","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB62|cit62","first-page":"700","article-title":"Neo-natal diabetes mellitus and cerebellar hypoplasia\/ agenesis: report of a new recessive syndrome","volume":"36","author":"Hoveyda","year":"1999","journal-title":"J Med Genet"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/ng1475","article-title":"Mutations in PTF1A cause pancreatic and cerebellar agenesis","volume":"36","author":"Sellick","year":"2004","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jmg.39.8.537","article-title":"Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syn-drome","volume":"39","author":"Wildin","year":"2002","journal-title":"J Med Genet"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/78085","article-title":"EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome","volume":"25","author":"Del\u00e9pine","year":"2000","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/15500","article-title":"Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus","volume":"23","author":"Malecki","year":"1999","journal-title":"Nat Gene"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.2337\/db10-0011","article-title":"Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities","volume":"59","author":"Rubio-Cabezas","year":"2010","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1007\/s00125-004-1576-3","article-title":"Neonatal diabetes, with hypoplastic pancreas, intestinal atresia and gall bladder hypoplasia: search for the aetiology of a new autosomal recessive syndrome","volume":"47","author":"Mitchell","year":"2004","journal-title":"Diabetologia"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nature08748","article-title":"Rfx6 directs islet formation and insulin production in mice and humans","volume":"463","author":"Smith","year":"2010","journal-title":"Nature"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1210\/jc.2009-1137","article-title":"Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families","volume":"94","author":"Rubio-Cabezas","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00431-002-0931-y","article-title":"Identification of a novel mutation in the GLUT2 gene in a patient with Fanconi-Bickel syndrome presenting with neonatal diabetes mellitus and galactosaemia","volume":"161","author":"Yoo","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ng1802","article-title":"Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism","volume":"38","author":"Sen\u00e9e","year":"2006","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/10372","article-title":"Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness","volume":"22","author":"Labay","year":"1999","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1067\/mpd.2002.127089","article-title":"Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases","volume":"141","author":"Metz","year":"2002","journal-title":"J Pediatr"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1586\/14737159.1.4.403","article-title":"Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes","volume":"1","author":"McCarthy","year":"2001","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/eje.0.1410379","article-title":"Neonatal diabetes mellitus with hypergalactosemia","volume":"141","author":"Kentrup","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1128\/MCB.01259-09","article-title":"Transcription factor Glis3, a novel critical player in the regulation of pancreatic beta-cell development and insulin gene expression","volume":"29","author":"Kang","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/10379","article-title":"The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter","volume":"22","author":"Fleming","year":"1999","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"476","DOI":"10.7861\/clinmedicine.5-5-476","article-title":"Molecular genetics goes to the diabetes clinic","volume":"5","author":"Hattersley","year":"2005","journal-title":"Clin Med"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00125-008-0942-y","article-title":"Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young","volume":"51","author":"Ellard","year":"2008","journal-title":"Diabetologia"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1399-5448.2009.00548.x","article-title":"Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM","volume":"11","author":"Mohamadi","year":"2010","journal-title":"Pediatr Diabetes"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1210\/jc.2004-0568","article-title":"Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 Gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel","volume":"89","author":"Gloyn","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1210\/jc.2006-2817","article-title":"Origin of de novo KCNJ11 mutations and risk of neonatal diabetes for subsequent siblings","volume":"92","author":"Edghill","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1464-5491.2007.02373.x","article-title":"Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation","volume":"25","author":"Slingerland","year":"2008","journal-title":"Diabet Med"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1210\/jc.2005-0096","article-title":"The C42R mutation in the Kir6.2 (KCNJ11) gene as a cause of transient neonatal diabetes, childhood diabetes, or later-onset, apparently type 2 diabetes mellitus","volume":"90","author":"Yorifuji","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2010.02409.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/humu.20838","article-title":"Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism","volume":"30","author":"Flanagan","year":"2009","journal-title":"Hum Mutat"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2010.02409.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2362.2010.02409.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T21:13:34Z","timestamp":1625346814000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2010.02409.x"}},"subtitle":["MOLECULAR GENETICS TESTING IN PNDM"],"short-title":[],"issued":{"date-parts":[[2010,11,4]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2010.02409.x","relation":{},"ISSN":["0014-2972"],"issn-type":[{"value":"0014-2972","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,4]]}}}